As of February 2024, there are 99 active lawsuits pending in Arizona multidistrict litigation (MDL) 3081, presided over by Judge David G. Campbell. Law firms are currently accepting Bard PowerPort cases, with expectations of a significant increase in filings. It’s crucial to note the statute of limitations for filing a lawsuit regarding the implanted port catheter, as it varies by state.
Recent updates on the lawsuits include:
- December 2023: The Arizona MDL was in its initial stages, with Judge David G. Campbell issuing several case management orders. A hearing was scheduled in January 2024 to discuss the transfer of additional cases into the MDL.
- October 2023: No Bard PowerPort pending lawsuits were reported in the MDL, but a total of 8,689 cases have been filed.
- August 2023: Over 50 Bard PowerPort lawsuits were filed, leading to a transfer order issued by the U.S. Judicial Panel on Multidistrict Litigation to centralize all claims under U.S. District Court Judge David G. Campbell.
- May 2023: Personal injury and wrongful death claims increased, prompting courts to petition for the centralization of claims into multidistrict litigation. Unlike class-action claims, lawsuits centralized in MDL remain individual cases, with each plaintiff presenting their own damages.
- April 2023: Lawsuits against Bard PowerPort catheter device manufacturers alleged injuries due to cracking and fracturing, leading to an increased risk of blood clots, internal damage, and infection.
- March 2020: The U.S. Food and Drug Administration issued a recall notice for several Bard PowerPort models due to incorrect tunneler tips.
People are filing lawsuits against Bard PowerPort manufacturers due to claims of faulty design increasing the risk of organ damage, infection, and blood clots. The device, implanted to facilitate medication delivery, has design defects causing high injection flow rates and catheter breakage.
Complications from Bard PowerPort malfunctions may include abnormal heart rhythms, blood clots, punctures in the heart, ruptured blood vessels, and more. Allegations suggest the manufacturer, Becton Dickinson (BD), concealed thousands of injury reports, potentially violating FDA regulations.
Eligibility to file a Bard PowerPort lawsuit includes experiencing a related injury after device implantation. Qualifying injuries range from blood clots to severe pain, with legal representation necessary to assess eligibility. It’s crucial to consult an attorney promptly, as statute of limitations restrictions apply.
In conclusion, understanding the ongoing Bard PowerPort lawsuits, recent updates, and qualification criteria is essential for individuals seeking legal recourse due to device-related injuries.
